EyePoint Pharmaceuticals, Inc. (EYPT) SEC Filings

EyePoint Pharmaceuticals, Inc. (EYPT) SEC EDGAR filings (8-K, 10-Q, DEF 14A, 10-K, 8-K/A), newest first; latest 8-K filed 2026-08-17. Every filing links to the canonical SEC document. First-party data.

SEC filings — source: EDGAR
FiledFormTitle
2026-08-178-K8-K filed 2026-08-17 by EyePoint, Inc.
2026-08-058-K8-K filed 2026-08-05 by EyePoint, Inc.
2026-08-0510-Q10-Q filed 2026-08-05 by EyePoint, Inc.
2026-07-308-K8-K filed 2026-07-30 by EyePoint, Inc.
2026-07-178-K8-K filed 2026-07-17 by EyePoint, Inc.
2026-06-228-K8-K filed 2026-06-22 by EyePoint, Inc.
2026-05-148-K8-K filed 2026-05-14 by EyePoint, Inc.
2026-05-0710-Q10-Q filed 2026-05-07 by EyePoint, Inc.
2026-05-068-K8-K filed 2026-05-06 by EyePoint, Inc.
2026-04-27DEF 14ADEF 14A filed 2026-04-27 by EyePoint, Inc.
2026-04-138-K8-K filed 2026-04-13 by EyePoint, Inc.
2026-03-208-K8-K filed 2026-03-20 by EyePoint, Inc.
2026-03-0510-K10-K filed 2026-03-05 by EyePoint, Inc.
2026-03-048-K8-K filed 2026-03-04 by EyePoint, Inc.
2026-03-028-K8-K filed 2026-03-02 by EyePoint, Inc.
2026-01-078-K8-K filed 2026-01-07 by EyePoint, Inc.
2025-12-088-K8-K filed 2025-12-08 by EyePoint, Inc.
2025-11-198-K8-K filed 2025-11-19 by EyePoint, Inc.
2025-11-068-K8-K filed 2025-11-06 by EyePoint, Inc.
2025-11-0610-Q10-Q filed 2025-11-06 by EyePoint, Inc.
2025-11-058-K8-K filed 2025-11-05 by EyePoint, Inc.
2025-10-178-K8-K filed 2025-10-17 by EyePoint, Inc.
2025-10-148-K8-K filed 2025-10-14 by EyePoint, Inc.
2025-08-0710-Q10-Q filed 2025-08-07 by EyePoint, Inc.
2025-08-068-K8-K filed 2025-08-06 by EyePoint, Inc.
2025-07-298-K/A8-K/A filed 2025-07-29 by EyePoint, Inc.
2025-06-208-K8-K filed 2025-06-20 by EyePoint, Inc.
2025-05-278-K8-K filed 2025-05-27 by EyePoint, Inc.
2025-05-0810-Q10-Q filed 2025-05-08 by EyePoint, Inc.
2025-05-078-K8-K filed 2025-05-07 by EyePoint, Inc.

EYPT overview · EYPT earnings · EYPT financials · EYPT KPIs · EYPT investor relations · EYPT ownership · EYPT peers

Data sourced from U.S. SEC EDGAR. Not personalized investment advice.